Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097370
Status:
TERMINATED
Last Update Posted:
2017-07-07
First Post:
2004-11-22
Brief Title:
Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline